Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
52.7K
-
Shares change
-
+23K
-
Total reported value, excl. options
-
$76.1K
-
Value change
-
+$18.6K
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$1.45
Significant Holders of IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) as of Q4 2024
13 filings reported holding IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK as of Q4 2024.
IMPACT BIOMEDICAL INC. - COMMON STOCK (IBO) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.7K shares
.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (20.8K shares), FNY Investment Advisers, LLC (12.6K shares), STATE STREET CORP (11.2K shares), UBS Group AG (4.25K shares), Tower Research Capital LLC (TRC) (3.76K shares), Newbridge Financial Services Group, Inc. (86 shares), WELLS FARGO & COMPANY/MN (29 shares), BANK OF AMERICA CORP /DE/ (17 shares), GROUP ONE TRADING LLC (1 shares), and MORGAN STANLEY (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.